成人免费xx,国产又黄又湿又刺激不卡网站,成人性视频app菠萝网站,色天天天天

Welcome to chemicalbook!
+1 (818) 612-2111
Inquriy
Try our best to find the right business for you.
Do not miss inquiry messages Please log in to view all inquiry messages.

Welcome back!

RFQ
skype
MY Account
Top
Postion:Product Catalog >API>Antibiotics>Tetracycline drugs>Methacycline hydrochloride
Methacycline hydrochloride
  • Methacycline hydrochloride

Methacycline hydrochloride NEW

Price $52 $81
Package 100mg 200mg
Min. Order:
Supply Ability: 10g
Update Time: 2024-11-06

Product Details

Product Name: Methacycline hydrochloride CAS No.: 3963-95-9
Purity: ≥98% Supply Ability: 10g
Release date: 2024/11/06

Product Introduction

Bioactivity

名稱Methacycline hydrochloride
描述Methacycline hydrochloride (Rondomycin) is a broad-spectrum semisynthetic antibiotic related to TETRACYCLINE but excreted more slowly and maintaining effective blood levels for a more extended period.
體外活性Methacycline, within pulmonary alveolar macrophages, does not alter the response gene of TGF-β1 nor attenuates the aggregation of inflammatory cells. Following tracheal aspiration of bleomycin, intraperitoneal injection of Methacycline at 100 mg/kg, starting on day 10, enhances survival rates by day 17. Methacycline mitigates bleomycin-induced classical EMT (Epithelial-Mesenchymal Transition) markers, including SNAIL1, TWIST1, type I collagen, fibronectin, and their mRNA expressions.
體內(nèi)活性Methacycline inhibits the TGF-β1-induced non-Smad signaling pathways, including the activation of c-Jun N-terminal kinase (JNK), p38, and Akt, without suppressing Smad or β-catenin transcriptional activities. It does not affect the baseline activities of JNK, p38, or Akt, nor the TGF-β1 response of lung fibroblasts. Additionally, methacycline inhibits the TGF-β1-induced expression of α-smooth muscle actin (α-SMA), SNAIL1, and type I collagen in primary alveolar epithelial cells.
存儲(chǔ)條件keep away from direct sunlight,store under nitrogen | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice.
溶解度DMSO : 27.5 mg/mL (57.43 mM)
關(guān)鍵字fibrosis | fibrogenesis | c-Jun | TGF-β1 | Methacycline | N-terminal | Inhibitor | p38 | inhibit | Methacycline hydrochloride | Bacterial | epithelial-mesenchymal | Antibiotic | kinase | Smad | transition | EMT | pulmonary | Methacycline Hydrochloride | Akt
相關(guān)產(chǎn)品Neomycin sulfate | Dimethyl sulfoxide
相關(guān)庫(kù)FDA上市及藥典收錄分子庫(kù) | 經(jīng)典已知活性庫(kù) | 藥物功能重定位化合物庫(kù) | 抑制劑庫(kù) | 微生物天然產(chǎn)物庫(kù) | FDA 上市藥物庫(kù) | 已知活性化合物庫(kù)

Company Profile Introduction

Target Molecule Corp. (TargetMol) is a global high-tech enterprise, headquartered in Boston, MA, specializing in chemical and biological research product and service to meet the research needs of global customers. TargetMol has evolved into one of the biggest global compound library and small molecule suppliers and a customer based on 40+ countries. TargetMol offers over 80 types of compound libraries and a wide range of high-quality research chemicals including inhibitors, activator, natural compounds, peptides, inhibitory antibodies, and novel life-science kits, for laboratory and scientific use. Besides, virtual screening service is also available for customers who would like to conduct the computer-aided drug discovery.

You may like

Recommended supplier

Product name Price   Suppliers Update time
$52.00/100mg
VIP3Y
TargetMol Chemicals Inc.
2024-11-06
$990.00/1ton
VIP1Y
HEBEI SHENGSUAN CHEMICAL INDUSTRY CO.,LTD
2024-08-19
$0.00/25Kg/Drum
VIP4Y
WUHAN FORTUNA CHEMICAL CO., LTD
2021-10-27
$15.00/1KG
Zhuozhou Wenxi import and Export Co., Ltd
2021-07-09
$210.00/1Kg/Bag
VIP4Y
Baoji Guokang Bio-Technology Co., Ltd.
2021-06-03
$8.00/1Kg/Bag
Longyan Tianhua Biological Technology Co., Ltd
2020-11-17
$0.00/1Kg
VIP5Y
Shaanxi Dideu Medichem Co. Ltd
2020-05-23
$8.00/1kg
VIP7Y
Career Henan Chemical Co
2018-12-24
$15.00/1KG
Zhuozhou Wenxi import and Export Co., Ltd
2021-07-08
$210.00/1KG
Zhuozhou Wenxi import and Export Co., Ltd
2021-07-03
  • Since: 2011-01-07
  • Address: 36?Washington?Street, Wellesley?Hills
INQUIRY